CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- 8-K/A Event Material agreement · Unregistered share sale · Bylaws or fiscal year change
- RW Other RW
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Open-market sale Director sold 2,000 shares at $1.56 ($3,116)
- 4/A Open-market buy Director bought 110,388 shares at an average $1.01 ($110,965)
- 4/A Open-market buy Director bought 110,388 shares at an average $1.01 ($110,965)
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-1 Offering Registration Statement
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
Page 1 of 20 · 398 filings